These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation. Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome. Talib AK; Takagi M; Shimane A; Nakano M; Hayashi T; Okajima K; Kentaro M; Fukada K; Kowase S; Kurosaki K; Nitta J; Nishizaki M; Yui Y; Talib A; Sato N; Kawamura Y; Hasebe N; Aita S; Sai E; Komatsu Y; Kuroki K; Kaneshiro T; Dongzu X; Tajiri K; Igarashi M; Yamasaki H; Murakoshi N; Kumagai K; Sekiguchi Y; Nogami A; Aonuma K Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e005631. PubMed ID: 30354308 [TBL] [Abstract][Full Text] [Related]
14. Surface ECG characteristics of ventricular tachyarrhythmias before degeneration into ventricular fibrillation in patients with Brugada-type ECG. Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Ohta M; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A Int Heart J; 2009 Jul; 50(4):477-87. PubMed ID: 19609052 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry). Nademanee K; Chung FP; Sacher F; Nogami A; Nakagawa H; Jiang C; Hocini M; Behr E; Veerakul G; Jan Smit J; Wilde AAM; Chen SA; Yamashiro K; Sakamoto Y; Morishima I; Das MK; Khongphatthanayothin A; Vardhanabhuti S; Haissaguerre M Circulation; 2023 May; 147(21):1568-1578. PubMed ID: 36960730 [TBL] [Abstract][Full Text] [Related]
16. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities. Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917 [TBL] [Abstract][Full Text] [Related]
17. Is this a philosophic issue? Do patients with drug-induced Brugada type ECG have poor prognosis? (Pro). Shimizu A Circ J; 2010 Nov; 74(11):2455-63. PubMed ID: 20962432 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome. Ueoka A; Morita H; Watanabe A; Morimoto Y; Kawada S; Tachibana M; Miyamoto M; Nakagawa K; Nishii N; Ito H J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748178 [TBL] [Abstract][Full Text] [Related]
19. Characteristic features of QRST integral mapping in patients with high risk Brugada syndrome. Kanahara M; Kai H; Toyomasu K; Yoshida T; Hiraki T; Sagawa K; Imaizumi T Circ J; 2007 Jan; 71(1):63-9. PubMed ID: 17186980 [TBL] [Abstract][Full Text] [Related]
20. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. Aiba T; Shimizu W; Hidaka I; Uemura K; Noda T; Zheng C; Kamiya A; Inagaki M; Sugimachi M; Sunagawa K J Am Coll Cardiol; 2006 May; 47(10):2074-85. PubMed ID: 16697328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]